The Effects of Bifidobacterium Probiotic Supplementation on Blood Glucose: A Systematic Review and Meta-Analysis of Animal Models and Clinical Evidence

Barengolts, 2019, The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: a meta-analysis of nine randomized controlled trials, Nutrients, 11, 671, 10.3390/nu11030671 Dallanora, 2018, Do probiotics effectively ameliorate glycemic control during gestational diabetes? A systematic review, Arch. Gynecol. Obstet., 298, 477, 10.1007/s00404-018-4809-2 Dong, 2019, Probiotic foods and supplements interventions for metabolic syndromes: a systematic review and meta-analysis of recent clinical trials, Ann. Nutr. Metab., 74, 224, 10.1159/000499028 2005 2011, Standards of medical care in diabetes––2011, Diabetes Care, 34, S11, 10.2337/dc11-S011 2006 Levitan, 2004, Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies, Arch. Intern. Med., 164, 2147, 10.1001/archinte.164.19.2147 Webb, 2011, Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study, Diabetologia, 54, 2237, 10.1007/s00125-011-2189-2 Xu, 2022, Role of probiotics/synbiotic supplementation in glycemic control: a critical umbrella review of meta-analyses of randomized controlled trials, Crit. Rev. Food Sci. Nutr., 1, 10.1080/10408398.2022.2117783 Ward, 2019, Projected U.S. state-level prevalence of adult obesity and severe obesity, N. Engl J. Med., 381, 2440, 10.1056/NEJMsa1909301 Bullard, 2018, Prevalence of diagnosed diabetes in adults by diabetes type — United States, 2016, MMWR Morb. Mortal Wkly Rep., 67, 359, 10.15585/mmwr.mm6712a2 Rittiphairoj, 2021, Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis, Adv. Nutr., 12, 722, 10.1093/advances/nmaa133 Ruan, 2015, Effect of probiotics on glycemic control: a systematic review and meta-analysis of randomized, controlled trials, PLOS ONE, 10, 10.1371/journal.pone.0132121 Salari, 2021, Effect of kefir beverage consumption on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials, Complement, Ther. Clin. Pract., 44, 101443, 10.1016/j.ctcp.2021.101443 Naseri, 2022, Probiotics and synbiotics supplementation improve glycemic control parameters in subjects with prediabetes and type 2 diabetes mellitus: a GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials, Pharmacol. Res., 184, 106399, 10.1016/j.phrs.2022.106399 Brandt, 2016, Phylogenetic analysis of the Bifidobacterium genus using glycolysis enzyme sequences, Front. Microbiol., 7, 657, 10.3389/fmicb.2016.00657 Lukjancenko, 2012, Comparative genomics of Bifidobacterium, Lactobacillus and related probiotic genera, Microb. Ecol., 63, 651, 10.1007/s00248-011-9948-y Tonucci, 2017, Gut microbiota and probiotics: focus on diabetes mellitus, Crit. Rev. Food Sci. Nutr., 57, 2296, 10.1080/10408398.2014.934438 Engevik, 2019, Bifidobacterium dentium fortifies the intestinal mucus layer via autophagy and calcium signaling pathways, MBio, 10, e01087, 10.1128/mBio.01087-19 Kailasapathy, 2000, Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp, Immunol. Cell. Biol., 78, 80, 10.1046/j.1440-1711.2000.00886.x Strozzi, 2008, Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains, J. Clin. Gastroenterol., 42, S179, 10.1097/MCG.0b013e31818087d8 O’Callaghan, 2016, Bifidobacteria and their role as members of the human gut microbiota, Front. Microbiol., 7, 925 Picard, 2005, Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits, Aliment. Pharmacol. Ther., 22, 495, 10.1111/j.1365-2036.2005.02615.x Page, 2021, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ, 372 n71 Aravani, 2021, Cardiometabolic syndrome: an update on available mouse models, Thromb. Haemost., 121, 703, 10.1055/s-0040-1721388 Kasiske, 1992, The zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury, Hypertension, 19, I110, 10.1161/01.HYP.19.1_Suppl.I110 Furman, 2021, Streptozotocin-induced diabetic models in mice and rats, Curr. Protoc., 1, e78, 10.1002/cpz1.78 Hooijmans, 2014, SYRCLE’s risk of bias tool for animal studies, BMC. Med. Res. Methodol., 14, 43, 10.1186/1471-2288-14-43 Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136/bmj.l4898 Balduzzi, 2019, How to perform a meta-analysis with R: a practical tutorial, Evid. Based Ment. Health., 22, 153, 10.1136/ebmental-2019-300117 Harrer, 2019 Viechtbauer, 2010, Conducting meta-analyses in R with the metafor package, J. Stat. Softw., 36, 1 Knapp, 2003, Improved tests for a random effects meta-regression with a single covariate, Stat. Med., 22, 2693, 10.1002/sim.1482 Takeshima, 2014, Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?, BMC. Med. Res. Methodol., 14, 30, 10.1186/1471-2288-14-30 2022 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 Viechtbauer, 2005, Bias and efficiency of meta-analytic variance estimators in the random-effects model, J. Educ. Behav. Stat., 30, 261, 10.3102/10769986030003261 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Caimari, 2017, Heat-killed Bifidobacterium animalis subsp. Lactis CECT 8145 increases lean mass and ameliorates metabolic syndrome in cafeteria-fed obese rats, J. Funct. Foods., 38, 251, 10.1016/j.jff.2017.09.029 Cano, 2013, Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice, Obesity (Silver Spring), 21, 2310, 10.1002/oby.20330 Huang, 2020, Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes, World J. Clin. Cases, 8, 6213, 10.12998/wjcc.v8.i24.6213 Moya-Pérez, 2015, Bifidobacterium pseudocatenulatum CECT 7765 reduces obesity-associated inflammation by restoring the lymphocyte–macrophage balance and gut microbiota structure in high-fat diet-fed mice, PLOS ONE, 10, 10.1371/journal.pone.0126976 Reichold, 2014, Bifidobacterium adolescentis protects from the development of nonalcoholic steatohepatitis in a mouse model, J. Nutr. Biochem., 25, 118, 10.1016/j.jnutbio.2013.09.011 Salazar, 2014, Immune modulating capability of two exopolysaccharide-producing Bifidobacterium strains in a wistar rat model, Biomed. Res. Int., 2014, 106290, 10.1155/2014/106290 Wang, 2015, Oral administration of Bifidobacterim bifidum for modulating microflora, acid and bile resistance, and physiological indices in mice, Can. J. Microbiol., 61, 155, 10.1139/cjm-2014-0694 Machado, 2021, Oral probiotic Bifidobacterium longum supplementation improves metabolic parameters and alters the expression of the renin-angiotensin system in obese mice liver, Biol. Res. Nurs., 23, 100, 10.1177/1099800420942942 Schellekens, 2021, Bifidobacterium longum counters the effects of obesity: partial successful translation from rodent to human, eBioMedicine, 63, 103176, 10.1016/j.ebiom.2020.103176 Aoki, 2017, A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation, Sci. Rep., 7, 43522, 10.1038/srep43522 Horiuchi, 2020, Bifidobacterium animalis subsp. lactis GCL2505 modulates host energy metabolism via the short-chain fatty acid receptor GPR43, Sci. Rep., 10, 4158, 10.1038/s41598-020-60984-6 Jiang, 2022, Bifidobacterium longum 070103 fermented milk improve glucose and lipid metabolism disorders by regulating gut microbiota in mice, Nutrients, 14, 4050, 10.3390/nu14194050 Kondo, 2010, Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity, Biosci. Biotechnol. Biochem., 74, 1656, 10.1271/bbb.100267 Li, 2020, Bifidobacterium from breastfed infant faeces prevent high-fat-diet-induced glucose tolerance impairment, mediated by the modulation of glucose intake and the incretin hormone secretion axis, J. Sci. Food Agric., 100, 3308, 10.1002/jsfa.10360 Stenman, 2014, Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice, Benef. Microbes., 5, 437, 10.3920/BM2014.0014 Stenman, 2015, Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice, Diabetol. Metab. Syndr., 7, 75, 10.1186/s13098-015-0075-7 Zhao, 2020, Selenium-enriched Bifidobacterium longum DD98 relieves metabolic alterations and liver injuries associated with obesity in high-fat diet-fed mice, J. Funct. Foods., 72, 104051, 10.1016/j.jff.2020.104051 Lim, 2017, Bifidobacterium adolescentis IM38 ameliorates high-fat diet–induced colitis in mice by inhibiting NF-κB activation and lipopolysaccharide production by gut microbiota, Nutr. Res., 41, 86, 10.1016/j.nutres.2017.04.003 Yde, 2021, Polydextrose with and without Bifidobacterium animalis ssp. lactis 420 drives the prevalence of Akkermansia and improves liver health in a multi-compartmental obesogenic mice study, PLOS ONE, 16, 10.1371/journal.pone.0260765 An, 2011, Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats, Lipids Health Dis, 10, 116, 10.1186/1476-511X-10-116 Bomhof, 2014, Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats, Obesity (Silver Spring), 22, 763, 10.1002/oby.20632 Le, 2014, Oral administration of Bifidobacterium spp. improves insulin resistance, induces adiponectin, and prevents inflammatory adipokine expressions, Biomedical. Res., 35, 303, 10.2220/biomedres.35.303 Ray, 2018, Bifidobacteria and its rice fermented products on diet induced obese mice: analysis of physical status, serum profile and gene expressions, Benef. Microbes., 9, 441, 10.3920/BM2017.0056 Almada, 2021, Wheat-durum pasta added of inactivated Bifidobacterium animalis decreases glucose and total cholesterol levels and modulates gut microbiota in healthy rats, Int. J. Food Sci. Nutr., 72, 781, 10.1080/09637486.2021.1877261 de Abreu Ribeiro Pereira, 2022, Combined effects of yacon flour and probiotic yogurt on the metabolic parameters and inflammatory and insulin signaling proteins in high-fat-diet-induced obese mice, J. Sci. Food Agric., 102, 7293, 10.1002/jsfa.12095 Yin, 2010, Effects of four Bifidobacteria on obesity in high-fat diet induced rats, World J. Gastroenterol., 16, 3394, 10.3748/wjg.v16.i27.3394 Zhu, 2018, Bifidobacteria attenuate the development of metabolic disorders, with inter- and intra-species differences, Food Funct, 9, 3509, 10.1039/C8FO00100F Carreras, 2018, Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats, Benef. Microbes., 9, 629, 10.3920/BM2017.0141 Mounts, 2015, Feeding soy with probiotic attenuates obesity-related metabolic syndrome traits in obese Zucker rats, Food Nutr. Sci., 6, 780 Plaza-Diaz, 2014, Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats, PLOS ONE, 9, 10.1371/journal.pone.0098401 Chen, 2011, Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression, Exp. Biol. Med., 236, 823, 10.1258/ebm.2011.010399 Hao, 2022, The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice, Food Funct, 13, 9947, 10.1039/D2FO01109C Zhang, 2020, Anti-diabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model, J. Funct. Foods., 67, 103843, 10.1016/j.jff.2020.103843 Qian, 2022, Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity, Nutrients, 14, 2479, 10.3390/nu14122479 Wang, 2020, Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners, Food Funct, 11, 5898, 10.1039/C9FO02761K Ben Othman, 2020, Effect of inactivated Bifidobacterium longum intake on obese diabetes model mice (TSOD), Food Res. Int., 129, 108792, 10.1016/j.foodres.2019.108792 Kim, 2014, The anti-diabetic activity of Bifidobacterium lactis HY8101 in vitro and in vivo, J. Appl. Microbiol., 117, 834, 10.1111/jam.12573 Ohno, 2004, Effects of Bifidobacterium bifidum G9-1 on hypercholesterolemic and obese diabetic animal models, Biosci. Microflora., 23, 109, 10.12938/bifidus.23.109 Zhao, 2020, Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice, Food Funct, 11, 6528, 10.1039/D0FO00180E Hsu, 2021, Exercise training combined with Bifidobacterium longum OLP-01 treatment regulates insulin resistance and physical performance in db/db mice, Food Funct, 12, 7728, 10.1039/D0FO02939D Culpepper, 2019, Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study, Benef. Microbes., 10, 497, 10.3920/BM2018.0151 Stenman, 2016, Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults—randomized controlled trial, eBioMedicine, 13, 190, 10.1016/j.ebiom.2016.10.036 Bernini, 2016, Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: a randomized trial. Effects of probiotics on metabolic syndrome, Nutrition, 32, 716, 10.1016/j.nut.2015.11.001 Minami, 2015, Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial, J. Nutr. Sci., 4, e17, 10.1017/jns.2015.5 Ming, 2021, Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study, Genome. Med., 13, 125, 10.1186/s13073-021-00942-7 Naumova, 2020, Human gut microbiome response to short-term Bifidobacterium-based probiotic treatment, Indian J. Microbiol., 60, 451, 10.1007/s12088-020-00888-1 Wang, 2019, Bifidobacterium bifidum TMC3115 can characteristically influence glucose and lipid profile and intestinal microbiota in the middle-aged and elderly, Probiotics Antimicrob. Proteins, 11, 1182, 10.1007/s12602-018-9441-8 Paul, 2022, The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: a systematic review, meta-analysis, and meta-regression of clinical trials, Pharmacol. Res., 185, 106520, 10.1016/j.phrs.2022.106520 Tiderencel, 2020, Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials, Diabetes Metab. Res. Rev., 36, 10.1002/dmrr.3213 Cani, 2007, Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia, Diabetologia, 50, 2374, 10.1007/s00125-007-0791-0 Meng, 2017, Consumption of Bifidobacterium animalis subsp. lactis BB-12 in yogurt reduced expression of TLR-2 on peripheral blood-derived monocytes and pro-inflammatory cytokine secretion in young adults, Eur. J. Nutr., 56, 649, 10.1007/s00394-015-1109-5 Arnegard, 2020, Sex as a biological variable: a 5-year progress report and call to action, J. Womens Health (Larchmt)., 29, 858, 10.1089/jwh.2019.8247 Mattia, 2008, Regulation of probiotic substances as ingredients in foods: premarket approval or “generally recognized as safe” notification, Clin. Infect. Dis., 46, S115, 10.1086/523329 Quigley, 2019, Prebiotics and probiotics in digestive health, Clin. Gastroenterol. Hepatol., 17, 333, 10.1016/j.cgh.2018.09.028 King, 2012, The use of animal models in diabetes research, Br. J. Pharmacol., 166, 877, 10.1111/j.1476-5381.2012.01911.x Flores, 2008, The effects of anesthetic agent and carrier gas on blood glucose and tissue uptake in mice undergoing dynamic FDG-PET imaging: sevoflurane and isoflurane compared in air and in oxygen, Mol. Imaging Biol., 10, 192, 10.1007/s11307-008-0137-4 Tabrizi, 2022, Proteins, 14, 1